Nilotinib

Nilotinib (brand name Tasigna, also known by the trade name Banolib in some regions) is an oral medication used primarily to treat chronic myelogenous leukemia (CML), specifically in patients with Philadelphia chromosome-positive (Ph+) CML. Nilotinib belongs to a class of drugs called tyrosine kinase inhibitors (TKIs) and works by targeting and inhibiting the BCR-ABL fusion protein, a key driver of CML.